Pesino Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 3.00 Cr
as on 14-12-2024
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 Cr
as on 14-12-2024
- Revenue 21.06%
(FY 2022)
- Profit 49.54%
(FY 2022)
- Ebitda 79.36%
(FY 2022)
- Net Worth 11.27%
(FY 2022)
- Total Assets 39.02%
(FY 2022)
About Pesino Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹1.50 Cr.
Shawn Agnelo, Shilpa Almeida, and Agnelo Almeida serve as directors at the Company.
- CIN/LLPIN
U24230MH2003PTC140865
- Company No.
140865
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jun 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pesino Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shawn Agnelo  | Director | 01-Apr-2019 | Current |
| Shilpa Almeida | Director | 12-Jun-2003 | Current |
| Agnelo Almeida | Director | 12-Jun-2003 | Current |
Financial Performance of Pesino Pharmaceuticals.
Pesino Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.06% increase. The company also saw a substantial improvement in profitability, with a 49.54% increase in profit. The company's net worth Soared by an impressive increase of 11.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pesino Pharmaceuticals?
Unlock access to Pesino Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Aug 2007 | ₹1.50 Cr | Open |
How Many Employees Work at Pesino Pharmaceuticals?
Unlock and access historical data on people associated with Pesino Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pesino Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pesino Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
